Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Ophthalmology. 2010 Apr 9;117(8):1554–1559.e1. doi: 10.1016/j.ophtha.2009.12.012

Table 3.

Odds Ratios, Confidence Intervals, and P-values for Single Nucleotide Polymorphisms in Age-Related Macular Degeneration-Associated Genes (CFH, LOC387715, C2, C3, APOE, and TLR3) in Age-Related Eye Disease Study Participants with Geographic Atrophy (N=114) and Age-Related Eye Disease Study Controls with no Age-Related Macular Degenerationa (N=448)

Gene SNP type Nb Genotypic OR (CI)c Genotypic P-value Allelic OR (CI)d Allelic P-Value
CFH
rs1061170
GA 107 7.36 (3.87 –13.97) <0.0001 2.77 (2.042–3.77) <0.0001
No AMD 437
LOC387715
rs10490924
GA 106 6.01 (3.48–10.38) <0.0001 3.67 (2.67–5.05) <0.0001
No AMD 436
C2
rs2230199
GA 113 - - 0.23 (0.07–0.75) 0.0134
No AMD 447
C3
rs9332739
GA 114 6.22 (2.79–13.85) <0.0001 2.5 (1.81–3.45) <0.0001
No AMD 448
APOE
rs7412
GA 112 - - 1.37 (0.84–2.22) 0.256
No AMD 447
APOE
rs429358
GA 113 - - 0.61 (0.37–0.99) 0.062
No AMD 443
TLR3
rs3775291
GA 114 1.55 (0.77–1.67) 0.149 1.22 (0.896–1.67) 0.233
No AMD 448
a

Less than 5 small drusen (<63 micron diameter) in both eyes

b

Number of participants genotyped

c

Risk homozygote vs. non-risk homozygote. For C2 and APOE, there was an insufficient frequency of the minor-allele homozygotes for calculation of genotypic odds ratios.

d

allelic odds ratio (confidence interval)